(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEURORIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEURORIVE

ST13

US500000090001862

Class

42

Filing

90001862

Registration

6578958

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

01/03/2022

Trademark type

Word

Nice classes

42

Filing date

06/15/2020

Registration date

12/07/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/07/2021

Last transaction

12/07/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Seoul, KR

Examiner

POLLACK, ALISON FRIEDBERG

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Neurorive Inc.

Representatives

Timur Slonim United One Law Group LLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of technology for biotechnology; research in the field of biotechnology; biotechnology servicesbiotechnology research; biomedical research services; laboratory research in the field of biology; biological research services; biological research and analysis; research in the field of biologics; drug discovery services; research and development of new products; pharmaceutical products development; development of pharmaceutical preparations and medicines; clinical testing of pharmaceutical medicines for others; scientific research in the field of pharmacy; medical studiesconducting scientific feasibility medical studies; medical research laboratory services; research and development in the field of peptides for medical purposes; research and development in the field of amino acids for medical purposes; research and development of technology in the field of medicinal chemical manufacturing; research for medical products

Publications

History of USPTO decisions and trademark events.

33 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/03/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/07/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

11/03/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/03/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/26/2021

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

10/26/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/24/2021

PUBO

PUBLISHED FOR OPPOSITION

08/24/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/15/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/15/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/15/2021

ALIE

ASSIGNED TO LIE

07/14/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/08/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/10/2021

GNSL

LETTER OF SUSPENSION E-MAILED

03/10/2021

CNSL

SUSPENSION LETTER WRITTEN

03/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/09/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/09/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/23/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/23/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/18/2020

GNRT

NON-FINAL ACTION E-MAILED

09/18/2020

CNRT

NON-FINAL ACTION WRITTEN

09/18/2020

DOCK

ASSIGNED TO EXAMINER

09/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2020

NWAP

NEW APPLICATION ENTERED

06/18/2020

Continuous trademark protection

Get notified about every new filing that threatens NEURORIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.